Molecular analysis of non-small cell lung cancer using a dual-targeted DNA and RNA comprehensive genomic profiling panel
Analysis of NSCLC with Todai OncoPanel detected many druggable targets. Its RNA panel may detect MET exon 14 skipping with high sensitivity.
Authors
- Hiroyuki Aburatani (ORCID: https://orcid.org/0000-0003-0438-1544)
- Katsutoshi Oda (ORCID: https://orcid.org/0000-0002-2468-9573)
- Tetsuo Ushiku (ORCID: https://orcid.org/0000-0002-1763-8380)
- Hideaki Isago (ORCID: https://orcid.org/0009-0006-2640-9746)
- Hidenori Kage (ORCID: https://orcid.org/0000-0003-3658-4442)
- Aya Shinozaki‐Ushiku (ORCID: https://orcid.org/0000-0002-0196-5643)
- Kousuke Watanabe (ORCID: https://orcid.org/0000-0003-4670-3679)
- Shinji Kohsaka (ORCID: https://orcid.org/0000-0001-8651-6136)
- Kenji Tatsuno (ORCID: https://orcid.org/0000-0002-3046-3941)
- Hiroyuki Mano (ORCID: https://orcid.org/0000-0003-4645-0181)
Institutions
- University of Tokyo Hospital (JP)
- The University of Tokyo (JP)
Publication Details
- Journal
- Respiratory Investigation
- Published
- 2024-08-09
- DOI
- https://doi.org/10.1016/j.resinv.2024.07.018
- Citations
- 5
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 1.17
Funders
- Japan Agency for Medical Research and Development
- Sysmex Corporation